GlobalMed Technologies Company, a company involved in international medical device manufacturing and sales, has collaborated with DermaConcepts, a US distributor of innovative aesthetic products and training, it was reported on Friday.

In the upcoming second quarter 2019 launch of GlycoAla, the contract states that DermaConcepts will be the product's official exclusive US distributor. GlycoAla is claimed to be the only photodynamic gel containing hyaluronic acid, a natural moisturiser that also uses an advanced glycosphere nanoparticle delivery system for enhanced stability and skin absorption. It is activated by red light during a single session or three treatments spread over a 12-week period to help decrease the appearance of pore size, fine lines, and wrinkles, which the company says results in a brighter and more hydrated-looking skin tone. It is additionally claimed that GlycoAla does not require a recovery period or have side effects typically associated with more aggressive techniques.

Sanders Ergas, president and CEO at GlobalMed Technologies Company, said, 'We are really excited about working with DermaConcepts. Our companies share the same vision of being first to market with advanced and efficacious products for skin care professionals to share with their clientele. We are completely convinced, after much due diligence that, as a top U.S. distributor of scientifically developed skin care products, DermaConcepts is the right choice to help us launch GlycoAla to physicians and medical spas in the United States.'